arthritis |health|medicinal chemistry|organic chemistry|analytical chemistry This investment allows Merck Frosst to discover new medications for respiratory conditions such as asthma, and inflammatory conditions such as arthritis.This amount represents 11% of R & D expenditures for the entire pharmaceutical industry in Canada. Merck Frosst is firmly rooted in Canada’s history of scientific research. In 2000, Merck Frosst invested over 100 million dollars in research and development. |
